Skip to Main Content

Paper Details

Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial.
Trials
3
2022
Author NameAffiliation
Joseph E AslanOregon Health and Science University
Thomas O MetzPacific Northwest National Laboratory
  • 1 - 2

Datasets

Release 1.2